11 February 2021 : Clinical Research
Risk Factors of Coronavirus Disease 2019-Related Mortality and Optimal Treatment Regimens: A Retrospective Study
Yuehong Wang1BC, Shuang Yao2CDEF, Xiaoling Liu3BDEF, Yinghao Cao4ABCEF, Yaling Wang5BF*, Mao Xie6AEFDOI: 10.12659/MSM.926751
Med Sci Monit 2021; 27:e926751
Figure 2 Kaplan-Meier survival curves of patients with COVID-19. (A) Survival curve of patients receiving single-agent antiviral therapy and those receiving combination antiviral therapy (P=0.004). (B) Survival curve of patients receiving single-agent anti-infection therapy and those receiving combination anti-infection therapy (P<0.001). (C) Overall survival for all patients based on administration of gamma globulin therapy (P<0.001). (D) Overall survival for all patients based on receiving other supportive treatment (Chinese medicine or other) (P=0.048).